129 related articles for article (PubMed ID: 11407442)
1. Effectiveness of targeted intervention and maintenance pharmacotherapy in conjunction with family intervention in schizophrenia.
Wiedemann G; Hahlweg K; Müller U; Feinstein E; Hank G; Dose M
Eur Arch Psychiatry Clin Neurosci; 2001; 251(2):72-84. PubMed ID: 11407442
[TBL] [Abstract][Full Text] [Related]
2. Principles and results of family therapy in schizophrenia.
Hahlweg K; Wiedemann G
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():108-15. PubMed ID: 10654116
[TBL] [Abstract][Full Text] [Related]
3. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
Hogarty GE
J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
[TBL] [Abstract][Full Text] [Related]
4. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients.
Hogarty GE; Greenwald D; Ulrich RF; Kornblith SJ; DiBarry AL; Cooley S; Carter M; Flesher S
Am J Psychiatry; 1997 Nov; 154(11):1514-24. PubMed ID: 9356558
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial relevance and benefit of neuroleptic maintenance: experience in the United Kingdom.
Leff J; Kuipers L; Berkowitz R; Eberlein-Fries R; Sturgeon D
J Clin Psychiatry; 1984 May; 45(5 Pt 2):43-9. PubMed ID: 6143747
[TBL] [Abstract][Full Text] [Related]
6. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion.
Hogarty GE; Anderson CM; Reiss DJ; Kornblith SJ; Greenwald DP; Javna CD; Madonia MJ
Arch Gen Psychiatry; 1986 Jul; 43(7):633-42. PubMed ID: 2872870
[TBL] [Abstract][Full Text] [Related]
7. Two strategies for family intervention in schizophrenia: a randomized trial in a Mediterranean environment.
Montero I; Asencio A; Hernández I; Masanet MJ; Lacruz M; Bellver F; Iborra M; Ruiz I
Schizophr Bull; 2001; 27(4):661-70. PubMed ID: 11824492
[TBL] [Abstract][Full Text] [Related]
8. A program for relapse prevention in schizophrenia: a controlled study.
Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
[TBL] [Abstract][Full Text] [Related]
10. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal study.
Falloon IR; Boyd JL; McGill CW; Williamson M; Razani J; Moss HB; Gilderman AM; Simpson GM
Arch Gen Psychiatry; 1985 Sep; 42(9):887-96. PubMed ID: 2864032
[TBL] [Abstract][Full Text] [Related]
11. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research Group.
Hogarty GE; Anderson CM; Reiss DJ; Kornblith SJ; Greenwald DP; Ulrich RF; Carter M
Arch Gen Psychiatry; 1991 Apr; 48(4):340-7. PubMed ID: 1672589
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenia: a study comparing a family therapy group following a paradoxical model plus psychodrugs and a group treated by the conventional clinical approach.
De Giacomo P; Pierri G; Santoni Rugiu A; Buonsante M; Vadruccio F; Zavoianni L
Acta Psychiatr Scand; 1997 Mar; 95(3):183-8. PubMed ID: 9111850
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study.
Girón M; Fernández-Yañez A; Mañá-Alvarenga S; Molina-Habas A; Nolasco A; Gómez-Beneyto M
Psychol Med; 2010 Jan; 40(1):73-84. PubMed ID: 19490746
[TBL] [Abstract][Full Text] [Related]
15. The effect of family intervention on chronic schizophrenics under individual psychosocial treatment: a 3-year study.
Tomaras V; Mavreas V; Economou M; Ioannovich E; Karydi V; Stefanis C
Soc Psychiatry Psychiatr Epidemiol; 2000 Nov; 35(11):487-93. PubMed ID: 11197923
[TBL] [Abstract][Full Text] [Related]
16. Early intervention, time-limited, targeted pharmacotherapy of schizophrenia.
Carpenter WT; Heinrichs DW
Schizophr Bull; 1983; 9(4):533-42. PubMed ID: 6140752
[TBL] [Abstract][Full Text] [Related]
17. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
[TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy of persons with schizophrenia.
Carpenter WT
J Clin Psychiatry; 1996; 57 Suppl 9():10-8. PubMed ID: 8823345
[TBL] [Abstract][Full Text] [Related]
19. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia.
Dellva MA; Tran P; Tollefson GD; Wentley AL; Beasley CM
Psychiatr Serv; 1997 Dec; 48(12):1571-7. PubMed ID: 9406266
[TBL] [Abstract][Full Text] [Related]
20. Low-dose zotepine in the maintenance treatment of schizophrenia.
Fleischhacker WW; Stuppäck C; Barnas C; Unterweger B; Hinterhuber H
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):61-3. PubMed ID: 2883685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
